Aditxt Signs Asset Purchase Agreement to Acquire Fifty Percent Ownership of Global Response Aid – with Rights to Manufacture and Market Broad-Spectrum Antiviral Drug Avigan

By /

This agreement is a significant step for Aditxt as it expands its portfolio to include innovative therapies for infectious diseases.

Scroll to Top